Paper Details

  1. Home
  2. Paper Details

Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication.

Author: ArmuzziA, CandelliM, CremoniniF, DaneseS, FranceschiF, GasbarriniA, GasbarriniG, OjettiV, PolaP, RomanoA, VenutiA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Triple rabeprazole-based eradicating regimens are effective and safe for the treatment of Helicobacter pylori (H. pylori) infection. The incidence of side effects was low and similar in the different three-drug regimens. Quadruple therapy, while effective as a second-line therapy, was associated with a significantly higher incidence of side effects compared to first-line treatment.
Paper Details　
Original Abstract of the Article :
BACKGROUND/AIMS: Helicobacter pylori (H. pylori) infection is one of the most common gastrointestinal diseases. An increasing number of people undergo different treatment options. Unfortunately, H. pylori therapy may be troublesome for drug side effects and inefficacious for resistance to antibiotic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11379334

データ提供：米国国立医学図書館（NLM）

Eradicating Helicobacter pylori: A Quest for Effective and Tolerable Antibiotics

[Helicobacter pylori] infection is a common cause of gastrointestinal problems. This study delves into the effectiveness and tolerability of different antibiotic regimens for eradicating this persistent bacteria. The researchers randomly assigned 193 patients to three different 7-day treatment groups, each receiving a combination of antibiotics. Their findings showed that all three triple therapy regimens were effective in eradicating [Helicobacter pylori] with similar eradication rates, suggesting that different antibiotic combinations may be equally effective. However, while the first-line therapies were well tolerated, the study observed a significantly higher incidence of side effects with the quadruple therapy used as a second-line treatment.

Navigating the Complexities of Helicobacter pylori Eradication

The study highlights the importance of finding the right balance between efficacy and tolerability when choosing antibiotic treatment regimens for [Helicobacter pylori]. While different antibiotic combinations may be effective, the incidence and severity of side effects can vary significantly. This knowledge can help physicians make informed decisions about treatment strategies for individual patients, optimizing treatment outcomes while minimizing discomfort and potential complications.

Helicobacter pylori: A Persistent Challenger

Understanding the effectiveness and tolerability of different antibiotic combinations is crucial for managing [Helicobacter pylori] infection. This study provides valuable insights into the complexities of treating this persistent bacteria, paving the way for more effective and personalized treatment approaches.

Dr. Camel's Conclusion

This research is like navigating a winding path through a dense desert of antibiotic options. The study helps us understand the effectiveness and tolerability of different pathways, allowing us to find the best route to successfully eradicate [Helicobacter pylori]. By learning from the experience of this research, we can better guide our treatment strategies and ensure that our patients experience the most effective and comfortable journey back to good health.

Date :
  1. Date Completed 2001-10-11
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

11379334

DOI: Digital Object Identifier

11379334

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.